New Long-Term treatment study offers hope for inflammatory bowel disease patients

NCT ID NCT05668013

Ongoing Disease control Sponsor: Teva Branded Pharmaceutical Products R&D LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing whether two different doses of an experimental medication called TEV-48574 can help control symptoms of moderate to severe Crohn's disease or ulcerative colitis over the long term. The medication is given as an injection under the skin every four weeks. The study includes 247 adults who previously responded to this medication in an earlier trial and will track their symptoms, gut health, and safety for up to 5.5 years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Teva Investigational Site 15357

Kissimmee, Florida, 34741, United States
Teva Investigational Site 15358

Liberty, Missouri, 64068, United States
Teva Investigational Site 15359

Pinellas Park, Florida, 33781, United States
Teva Investigational Site 15361

Tyler, Texas, 75701, United States
Teva Investigational Site 15364

Salt Lake City, Utah, 84124, United States
Teva Investigational Site 15366

Katy, Texas, 77494, United States
Teva Investigational Site 15367

Kansas City, Kansas, 66160, United States
Teva Investigational Site 15369

Las Vegas, Nevada, 89128., United States
Teva Investigational Site 15373

St Louis, Missouri, 63110, United States
Teva Investigational Site 15374

San Antonio, Texas, 78229, United States
Teva Investigational Site 15375

Orlando, Florida, 32803, United States
Teva Investigational Site 15556

San Diego, California, 92103, United States
Teva Investigational Site 15559

Harlingen, Texas, 78550, United States
Teva Investigational Site 15565

Southlake, Texas, 76092, United States
Teva Investigational Site 15567

Gurnee, Illinois, 60031, United States
Teva Investigational Site 15574

New Albany, Indiana, 47150, United States
Teva Investigational Site 15575

Louisville, Kentucky, 40218, United States
Teva Investigational Site 15750

Beavercreek, Ohio, 45440, United States
Teva Investigational Site 30284

Rozzano, 20089, Italy
Teva Investigational Site 30285

Milan, 20132, Italy
Teva Investigational Site 30286

Milan, 20157, Italy
Teva Investigational Site 31292

Valencia, 46026, Spain
Teva Investigational Site 31293

Huelva, 21005, Spain
Teva Investigational Site 31318

Santiago de Compostela, 15702, Spain
Teva Investigational Site 32793

Kiel, 24105, Germany
Teva Investigational Site 32794

Ulm, 89081, Germany
Teva Investigational Site 32795

Tübingen, 72076, Germany
Teva Investigational Site 32874

Wipperfürth, 51688, Germany
Teva Investigational Site 33056

Vienna, 1090, Austria
Teva Investigational Site 34305

London, SE1 9RT, United Kingdom
Teva Investigational Site 41015

Lorenskog, 1478, Norway
Teva Investigational Site 51334

Budapest, 1085, Hungary
Teva Investigational Site 51335

Budapest, H-1033, Hungary
Teva Investigational Site 51338

Vác, H-2600, Hungary
Teva Investigational Site 53508

Szczecin, 71-434, Poland
Teva Investigational Site 53509

Zamość, 22-400, Poland
Teva Investigational Site 53510

Wroclaw, 52-416, Poland
Teva Investigational Site 53511

Łęczna, 21-010, Poland
Teva Investigational Site 53512

Krakow, 31-506, Poland
Teva Investigational Site 53515

Lodz, 90-752, Poland
Teva Investigational Site 53516

Poznan, 60-529, Poland
Teva Investigational Site 53518

Nowy Targ, 34-400, Poland
Teva Investigational Site 53519

Szczecin, 71-685, Poland
Teva Investigational Site 53520

Wroclaw, 53-673, Poland
Teva Investigational Site 53542

Częstochowa, 42-202, Poland
Teva Investigational Site 53543

Elblag, 82-300, Poland
Teva Investigational Site 53544

Gdansk, 80-382, Poland
Teva Investigational Site 53546

Katowice, 40-040, Poland
Teva Investigational Site 53547

Kłodzko, 57-300, Poland
Teva Investigational Site 53548

Krakow, 31-156, Poland
Teva Investigational Site 53549

Poznan, 54-144, Poland
Teva Investigational Site 53550

Sopot, 81-756, Poland
Teva Investigational Site 53551

Staszów, 28-200, Poland
Teva Investigational Site 53553

Torun, 87-100, Poland
Teva Investigational Site 53554

Wadowice, 34-100, Poland
Teva Investigational Site 53555

Warsaw, 04-501, Poland
Teva Investigational Site 53556

Warsaw, 02-786, Poland
Teva Investigational Site 53557

Warsaw, 00-189, Poland
Teva Investigational Site 53560

Krakow, 30-363, Poland
Teva Investigational Site 53562

Wroclaw, 53-611, Poland
Teva Investigational Site 53563

Poznan, 54-144, Poland
Teva Investigational Site 53565

Bydgoszcz, 85-794, Poland
Teva Investigational Site 53566

Poznan, 60-702, Poland
Teva Investigational Site 53567

Wroclaw, 53-149, Poland
Teva Investigational Site 53570

Warsaw, 02-672, Poland
Teva Investigational Site 54220

Slaný, 274 01, Czechia
Teva Investigational Site 54221

Brno, 615 00, Czechia
Teva Investigational Site 54222

Klatovy, 339 01, Czechia
Teva Investigational Site 58322

Uzhhorod, 88000, Ukraine
Teva Investigational Site 58324

Ivano-Frankivsk, 76008, Ukraine
Teva Investigational Site 58325

Lviv, 79010, Ukraine
Teva Investigational Site 58327

Chernivtsi, 58002, Ukraine
Teva Investigational Site 58329

Lviv, 79000, Ukraine
Teva Investigational Site 58330

Vinnytsia, 21018, Ukraine
Teva Investigational Site 58331

Vinnytsia, 21018, Ukraine
Teva Investigational Site 58332

Lviv, 79010, Ukraine
Teva Investigational Site 59196

Sofia, 1784, Bulgaria
Teva Investigational Site 59197

Sofia, 1618, Bulgaria
Teva Investigational Site 59243

Gorna Oryahovitsa, 5100, Bulgaria
Teva Investigational Site 62071

Košice, 040 13, Slovakia
Teva Investigational Site 62073

Bratislava, 811 09, Slovakia
Teva Investigational Site 62074

Bardejov, 085 01, Slovakia
Teva Investigational Site 62076

Prešov, 080 01, Slovakia
Teva Investigational Site 62097

Prešov, 080 01, Slovakia
Teva Investigational Site 80179

Afula, 1834111, Israel
Teva Investigational Site 80191

Beersheba, 8410101, Israel
Teva Investigational Site 81052

Tbilisi, 0119, Georgia
Teva Investigational Site 81053

Tbilisi, 0180, Georgia
Teva Investigational Site 84110

Kashiwa, 277-0871, Japan
Teva Investigational Site 84111

Toyama, 930-8550, Japan
Teva Investigational Site 84114

Sakura, 285-8741, Japan
Teva Investigational Site 84116

Shinjuku, 169-0073, Japan
Teva Investigational Site 84117

Minato, 108-8642, Japan

Conditions

Explore the condition pages connected to this study.

COLITIS, ULCERATIVE CROHN DISEASE